Savant Capital LLC Sells 2,559 Shares of Danaher Corporation $DHR

Savant Capital LLC reduced its holdings in Danaher Corporation (NYSE:DHR) by 4.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,032 shares of the conglomerate’s stock after selling 2,559 shares during the quarter. Savant Capital LLC’s holdings in Danaher were worth $10,118,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Danaher by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 60,769,587 shares of the conglomerate’s stock worth $12,004,424,000 after buying an additional 788,499 shares in the last quarter. Geode Capital Management LLC increased its position in Danaher by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 13,726,194 shares of the conglomerate’s stock valued at $2,697,800,000 after acquiring an additional 81,670 shares in the last quarter. Norges Bank bought a new position in shares of Danaher in the second quarter worth about $1,979,503,000. Generation Investment Management LLP lifted its position in shares of Danaher by 56.2% during the second quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate’s stock worth $980,914,000 after purchasing an additional 1,787,522 shares in the last quarter. Finally, Franklin Resources Inc. grew its stake in shares of Danaher by 4.0% during the second quarter. Franklin Resources Inc. now owns 4,822,442 shares of the conglomerate’s stock valued at $952,625,000 after purchasing an additional 186,357 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

DHR stock opened at $219.31 on Thursday. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The firm has a market cap of $154.91 billion, a PE ratio of 43.51, a P/E/G ratio of 2.93 and a beta of 0.91. The business’s 50-day moving average price is $230.07 and its two-hundred day moving average price is $214.68.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period last year, the company posted $2.14 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. As a group, research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio is currently 25.40%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on DHR shares. Robert W. Baird set a $251.00 target price on Danaher in a research note on Thursday, January 29th. Leerink Partners raised their price target on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a report on Friday, January 16th. Wells Fargo & Company lifted their price objective on Danaher from $230.00 to $240.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. TD Cowen restated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $252.32.

Insider Activity

In related news, Director Teri List sold 3,298 shares of Danaher stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the sale, the director owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president directly owned 2,625 shares of the company’s stock, valued at $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 30,248 shares of company stock worth $6,609,663 in the last quarter. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.